Neuhofstrasse 30, 6340 Baar

Zugo

Sulla carta dei registriSulla carta federale (map.geo.admin.ch)

Società attive
7
In liquidazione
0
Cancellate
4
Trasferite
0

Società a questo indirizzo

TutteAttivaIn liquidazioneCancellata

Apellis International GmbH

CHE-200.662.403 · Società a garanzia limitata · iscritta il 8 mar 2019

Apellis Schweiz GmbH

CHE-292.609.279 · Società a garanzia limitata · iscritta il 3 mag 2023

Biogen Digital Health International GmbH

CHE-349.441.832 · Società a garanzia limitata · iscritta il 30 giu 2022

Biogen International GmbH

CHE-108.135.087 · Società a garanzia limitata · iscritta il 15 mag 2007

Biogen International Neuroscience GmbH

CHE-116.234.774 · Società a garanzia limitata · iscritta il 22 nov 2010

Biogen Management Services GmbH

CHE-114.377.078 · Società a garanzia limitata · iscritta il 26 giu 2008

Biogen Switzerland AG

CHE-108.460.535 · Società anonima · iscritta il 23 apr 1996

Biogen Swiss Investments GmbH

CHE-375.054.659 · Società a garanzia limitata · Cancellata

Biogen Swiss Manufacturing GmbH

CHE-437.092.642 · Società a garanzia limitata · Cancellata · iscritta il 29 mag 2015

Biogen Switzerland Holdings GmbH

CHE-334.372.642 · Società a garanzia limitata · Cancellata · iscritta il 26 mag 2015

Eidetica Biopharma GmbH in Liquidation

CHE-113.921.826 · Società a garanzia limitata · Cancellata

Iscrizioni a questo indirizzo

Domande di costruzione, procedure FUSC, avvisi dei fogli ufficiali e titoli di proprietà intellettuale che indicano questo indirizzo per una delle loro parti.

Liquidationsschuldenruf Eidetica Biopharma GmbH in Liquidation

Procedura FUSC · Eidetica Biopharma GmbH in Liquidation (dissolved) · 28 gen 2025

Schuldenruf infolge Fusion nach FusG Reata Swiss International GmbH mit Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 13 dic 2024

Schuldenruf infolge Fusion nach FusG Reata Swiss International GmbH mit Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 12 dic 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 25 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen Swiss Manufacturing GmbH (transmitting) · 25 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen Swiss Manufacturing GmbH (transmitting) · 22 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 22 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen Swiss Manufacturing GmbH (transmitting) · 21 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Manufacturing GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 21 mar 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Switzerland Holdings GmbH with Biogen International GmbH

Procedura FUSC · Biogen Switzerland Holdings GmbH (transmitting) · 31 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Investments GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 31 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Investments GmbH with Biogen International GmbH

Procedura FUSC · Biogen Swiss Investments GmbH (transmitting) · 31 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Switzerland Holdings GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 31 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Switzerland Holdings GmbH with Biogen International GmbH

Procedura FUSC · Biogen Switzerland Holdings GmbH (transmitting) · 30 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Investments GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 30 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Swiss Investments GmbH with Biogen International GmbH

Procedura FUSC · Biogen Swiss Investments GmbH (transmitting) · 30 gen 2024

Call to creditors following the merger of companies limited by shares acc. MerA Biogen Switzerland Holdings GmbH with Biogen International GmbH

Procedura FUSC · Biogen International GmbH (acquiring) · 30 gen 2024

ILYRATOSI

Marchio · Biogen International GmbH (titolare) · 3 feb 2023

TOFIDENCE

Marchio · Biogen International GmbH (titolare) · 3 feb 2023

BYOOVIZ

Marchio · Biogen International GmbH (titolare) · 22 gen 2021

IMRALDI

Marchio · Biogen International GmbH (titolare) · 29 mar 2019

ANTIKÖRPER-ABHÄNGIGER ZELLULÄRER PHAGOZYTOSE ASSAY ZUR ZUVERLÄSSIGEN MESSUNG DER AUFNAHME VON AGGREGIERTEN PROTEINEN

Brevetto · Biogen International Neuroscience GmbH (titolare) · 14 mar 2017

FLIXABI

Marchio · Biogen International GmbH (titolare) · 15 ott 2015

BENEPALI

Marchio · Biogen International GmbH (titolare) · 10 lug 2015

MENSCHLICHE ANTI-TAU-ANTIKÖRPER

Brevetto · Biogen International Neuroscience GmbH (titolare) · 20 dic 2013

TDP-43-SPEZIFISCHE BINDUNGSMOLEKÜLE

Brevetto · Biogen International Neuroscience GmbH (titolare) · 26 ott 2012

ANTI-ALPHA-SYNUKLEIN-BINDENDE MOLEKÜLE

Brevetto · Biogen International Neuroscience GmbH (titolare) · 22 giu 2012

MENSCHLICHE ANTI-ALPHA-SYNUCLEIN-ANTIKÖRPER

Brevetto · Biogen International Neuroscience GmbH (titolare) · 21 dic 2009

DIALKYLFUMARATE ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN

Brevetto · Biogen International GmbH (titolare) · 29 ott 1999

RIMPOVIZ

Marchio · Biogen International GmbH (titolare)

OPAXVIZ

Marchio · Biogen International GmbH (titolare)

Altri ingressi di questo edificio

Neuhofstrasse 32, 6340 Baar

2 iscrizioni

Neuhofstrasse 34, 6340 Baar

6 iscrizioni

Nelle vicinanze

Gli indirizzi entro 250 m con società, avvocati o domande di costruzione, i più vicini prima.

Neuhofstrasse 34, 6340 Baar

35 m · Società: 4

Neuhofstrasse 32, 6340 Baar

47 m · Società: 1

Neuhofstrasse 24, 6340 Baar

61 m · Società: 38

Neuhofstrasse 12, 6340 Baar

86 m · Società: 101

Neuhofstrasse 22, 6340 Baar

95 m · Società: 16

Neuhofstrasse 20, 6340 Baar

98 m · Società: 14

Neuhofstrasse 8, 6340 Baar

106 m · Società: 7

Neuhofstrasse 10, 6340 Baar

120 m · Società: 7

Neuhofstrasse 6, 6340 Baar

121 m · Società: 2

Oberneuhofstrasse 2, 6340 Baar

174 m · Società: 4